Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

What is RPRX's next move?

|Includes: Repros Therapeutics Inc. (RPRX)

Be wary and alert!

For the past year, I have exposed the absurd nature of the Androxal [Enclomiphene] indications. Now, with Proellex dead, RPRX is sure to pull its next con game with Androxal. This is all they have left until they come up with another huge market breakthrough [LMAOROTFPIMP]. They will start to play this scam with anyone that will listen. That is anyone with money. Whoever steps up to fund the Androxal indications is a complete idiot, imbecile, buffoon, etc. [choose your adjective].